<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34171458</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.</ArticleTitle><Pagination><StartPage>1250</StartPage><EndPage>1261</EndPage><MedlinePgn>1250-1261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2021.06.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(21)00335-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the range of cardiac sequelae after COVID-19 recovery.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021).</AbstractText><AbstractText Label="STUDY ELIGIBILITY CRITERIA" NlmCategory="METHODS">Prospective and retrospective studies, case reports and case series.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients assessed for cardiac manifestations after COVID-19 recovery.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="METHODS">Severe acute respiratory syndrome coronavirus 2 infection diagnosed by PCR.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-five studies (fifteen prospective cohort, seven case reports, five cross-sectional, four case series, three retrospective cohort and one ambidirectional cohort) evaluating cardiac sequelae in 52&#xa0;609 patients were included. Twenty-nine studies used objective cardiac assessments, mostly cardiac magnetic resonance imaging (CMR) in 16 studies, echocardiography in 15, electrocardiography (ECG) in 16 and cardiac biomarkers in 18. Most studies had a fair risk of bias. The median time from diagnosis/recovery to cardiac assessment was 48&#xa0;days (1-180&#xa0;days). Common short-term cardiac abnormalities (&lt;3&#xa0;months) included increased T1 (proportion: 30%), T2 (16%), pericardial effusion (15%) and late gadolinium enhancement (11%) on CMR, with symptoms such as chest pain (25%) and dyspnoea (36%). In the medium term (3-6&#xa0;months), common changes included reduced left ventricular global longitudinal strain (30%) and late gadolinium enhancement (10%) on CMR, diastolic dysfunction (40%) on echocardiography and elevated N-terminal proB-type natriuretic peptide (18%). In addition, COVID-19 survivors had higher risk (risk ratio 3; 95% CI 2.7-3.2) of developing heart failure, arrythmias and myocardial infarction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">COVID-19 appears to be associated with persistent/de novo cardiac injury after recovery, particularly subclinical myocardial injury in the earlier phase and diastolic dysfunction later. Larger well-designed and controlled studies with baseline assessments are needed to better measure the extent of cardiac injury and its clinical impact.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Mohammad Said</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy; Unit of Infectious and Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolino</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy; Unit of Infectious and Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania 'L. Vanvitelli', Naples, Italy; Unit of Infectious and Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durante-Mangoni</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Precision Medicine, University of Campania 'L. Vanvitelli', Naples, Italy; Unit of Infectious and Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, Naples, Italy. Electronic address: emanuele.durante@unicampania.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Monaldi Hospital Cardiovascular Infection Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="N">Magnetic Resonance Imaging, Cine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiac sequelae</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Heart injury</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Durante-Mangoni</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Iossa</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bertolino</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ursi</LastName><ForeName>Maria Paola</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karruli</LastName><ForeName>Arta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zampino</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bernardo</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ruocco</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Microbiology, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dialetto</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Echocardiography, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Covino</LastName><ForeName>Franco Enrico</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Echocardiography, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Manduca</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Echocardiography, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Della Corte</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Feo</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Vivo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Electrophysiology, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Rimini</LastName><ForeName>Maria Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Nuclear Medicine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Galdieri</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Italy.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>20</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34171458</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pii">S1198-743X(21)00335-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . 2021. WHO coronavirus disease (COVID-19) dashboard.https://covid19.who.int/ [Webpage] (updated 5/12/2021). Available from:</Citation></Reference><Reference><Citation>Lai C.C., Ko W.C., Lee P.I., Jean S.S., Hsueh P.R. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56:106024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243791</ArticleId><ArticleId IdType="pubmed">32450197</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar S., Arora S., Kumar A., Jaswaney R., Faisaluddin M., Ammad Ud Din M., et al. A&#xa0;systematic review of the cardiovascular manifestations and outcomes in the setting of coronavirus-19 disease. Clin Med Insights Cardiol. 2020;14 1179546820977196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716078</ArticleId><ArticleId IdType="pubmed">33312009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R., Barreiro-Perez M., Martin-Garcia A., Almeida J., Villacorta E., Perez-Pons A., et al. Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv. 2020 Preprint.</Citation></Reference><Reference><Citation>JB Institute . 2021. JBI critical appraisal checklist for analytical cross sectional studies 2020.https://jbi.global/sites/default/files/2020-08/Checklist_for_Analytical_Cross_Sectional_Studies.pdf Available from:</Citation></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Marrazzo T., Florio M.T., Durante-Mangoni E. The Monaldi hospital cardiovascular infection study group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med. 2021:1&#x2013;11. doi: 10.1007/s11739-021-02763-3. Epub ahead of print. PMID: 34046852; PMCID: PMC8158084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02763-3</ArticleId><ArticleId IdType="pmc">PMC8158084</ArticleId><ArticleId IdType="pubmed">34046852</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Golemi Minga I., Golemi L., Tafur A., Pursnani A. The novel coronavirus disease (COVID-19) and its impact on cardiovascular disease. Cardiol Rev. 2020;28:163&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">32427637</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleszewski J.J., Young P.M., Ackerman M.J., Halushka M.K. An urgent need for studies of the late effects of SARS-CoV-2 on the cardiovascular system. Circulation. 2021;143:1271&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996057</ArticleId><ArticleId IdType="pubmed">32969710</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imag. 2020;13:2330&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegrante J.P., Auld M.E., Natarajan S. Preventing COVID-19 and its sequela: &#x201c;there is no magic bullet. It's just behaviors&#x201d;. Am J Prev Med. 2020;59:288&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260531</ArticleId><ArticleId IdType="pubmed">32591282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau D., McAlister F.A. Implications of the COVID-19 pandemic for cardiovascular disease and risk factor management. Can J Cardiol. 2021;37:722&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667463</ArticleId><ArticleId IdType="pubmed">33212203</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH . 2021. COVID-19 Clinical management, Living guidance.https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1 Available from:</Citation></Reference><Reference><Citation>Organization WH . 2020. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf Available from:</Citation></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A., editors. Open forum infectious diseases. 2020. Postacute COVID-19: an overview and approach to classification.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>JB Institute . 2021. JBI critical appraisal checklist for case reports 2020.https://jbi.global/sites/default/files/2020-08/Checklist_for_Case_Reports.pdf Available from:</Citation></Reference><Reference><Citation>JB Institute . 2021. Checklist for case series critical appraisal tools for use in JBI systematic reviews 2020.https://jbi.global/sites/default/files/2020-08/Checklist_for_Case_Series.pdf Available from:</Citation></Reference><Reference><Citation>Brito D., Meester S., Yanamala N., Patel H.B., Balcik B.J., Casaclang-Verzosa G., et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imag. 2021;14:541&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Umapathi T., Chua K., Chia Y.W., Wong S.W., Tan G.W.L., et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J&#xa0;Thromb Thrombolysis. 2021;51:971&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648538</ArticleId><ArticleId IdType="pubmed">33159640</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J., Myall K., Lam J.L., Mason T., Mukherjee B., West A., et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021;76:408&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C.E., Kussman A., Christle J.W., Froelicher V., Wheeler M.T., Moneghetti K.J. Findings from cardiovascular evaluation of NCAA Division I collegiate student-athletes after asymptomatic or mildly symptomatic SARS-CoV-2 infection. medRxiv. 2021 Preprint.</Citation><ArticleIdList><ArticleId IdType="pubmed">34173780</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A., Iqbal K., Ali S.A., Azim D., Farid E., Baig M.D., et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagia P., Ojha V., Naik N., Sharma S. Myocardial fibrosis detected by cardiovascular magnetic resonance in absence of myocardial oedema in a patient recovered from COVID-19. BMJ Case Rep. 2020;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10577794</ArticleId><ArticleId IdType="pubmed">33334776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek L.A., Marczak M., Milosz-Wieczorek B., Konopka M., Braksator W., Drygas W., et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J&#xa0;Magn Reson Imag. 2021;53:1723&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol M., Cacoub L., Baudet M., Nahmani Y., Cacoub P., Cohen-Solal A., et al. Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome. ESC Heart Fail. 2020;7:4371&#x2013;4376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755006</ArticleId><ArticleId IdType="pubmed">33107217</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S., Tong M.S., Borchers J., Zareba K.M., Obarski T.P., Simonetti O.P., et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A., Balfanz P., Cornelissen C., Muller A., Bergs I., Marx N., et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wang H., Zhao R., Wang T., Zhu Y., Qian Y., et al. Elevated extracellular volume fraction and reduced global longitudinal strains in patients recovered from COVID-19 without clinical cardiac findings. Radiology. 2021:203998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808090</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Morales M.D., Pell R., Rubero J., Ganti L. Acute myopericarditis in the post COVID-19 recovery phase. Cureus. 2020;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707144</ArticleId><ArticleId IdType="pubmed">33274129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardari A., Tabarsi P., Borhany H., Mohiaddin R., Houshmand G. Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imag. 2021;22:131&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574602</ArticleId><ArticleId IdType="pubmed">32462177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi L.A., Colussi G., Bulfone L., Brosolo G., Da Porto A., Peghin M., et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol. 2021;110:1063&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820534</ArticleId><ArticleId IdType="pubmed">33481096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C., Sherif M., Anker M.S., Geisel D., Kuehne T., Kelle S. COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture. ESC Heart Fail. 2021;8:971&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006695</ArticleId><ArticleId IdType="pubmed">33410259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li R., Zhou Z., Jiang H., Yan Z., Tao X., et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J&#xa0;Cardiovasc Magn Reson. 2021;23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Xu H., Jiang H., Wang L., Lu C., Wei X., et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020;113:657&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F., Gemelli Against C-P-ACSG Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Catena C., Colussi G., Bulfone L., Da Porto A., Tascini C., Sechi L.A. Echocardiographic comparison of COVID-19 patients with or without prior biochemical evidence of cardiac injury after recovery. J&#xa0;Am Soc Echocardiogr. 2021;34:193&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580530</ArticleId><ArticleId IdType="pubmed">33243582</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf M.A., Antoni M.L., Ter Kuile M.M., Arbous M.S., Duinisveld A.J.F., Feltkamp M.C.W., et al. Short-term outpatient follow-up of COVID-19 patients: a multidisciplinary approach. EClinicalMed. 2021;32:100731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843037</ArticleId><ArticleId IdType="pubmed">33532720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng M.-Y., Ferreira V.M., Leung S.T., Yin Lee J.C., Ho-Tung Fong A., To Liu R.W., et al. Patients recovered from COVID-19 show ongoing subclinical myocarditis as revealed by cardiac magnetic resonance imaging. Cardiovasc Imag. 2020;13:2476&#x2013;2478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455163</ArticleId><ArticleId IdType="pubmed">33153536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervaat F.E., Houthuizen P. Case report of SARS Co-V2 infection, acute pulmonary embolism, and right ventricular thrombus. Eur Heart J Case Rep. 2020;4:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890674</ArticleId><ArticleId IdType="pubmed">33623859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Santis L.V.-D., P&#xe9;rez-Camacho I., Sobrino B., Gonz&#xe1;lez G.E., Ru&#xed;z-Mesa J.D., Plata A., et al. Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study. medRxiv. 2020 Preprint.</Citation></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., The P.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse A., Rajagopal R., Y&#xfc;cel S., Beller E., &#xd6;ner A., Streckenbach F., et al. Cardiac MRI&#x2014;update 2020. Der Radiologe. 2020;60:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">32385547</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellhorn P., Klingel K., Burgstahler C. Return to sports after COVID-19 infection. Eur Heart J. 2020;41:4382&#x2013;4384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314071</ArticleId><ArticleId IdType="pubmed">32432700</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.J., Salerno M., Dharmakumar R., Jerosch-Herold M. T1 Mapping: basic techniques and clinical applications. JACC: Cardiovasc Imag. 2016;9:67&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26762877</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojar R., Varma N., Child N., Goodman B., Jabbour A., Yu C.Y., et al. T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Circ Cardiovasc Imag. 2015;8</Citation><ArticleIdList><ArticleId IdType="pubmed">26659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Freaney P.M., Shah S.J., Khan S.S. COVID-19 and heart failure with preserved ejection fraction. JAMA. 2020;324:1499&#x2013;1500.</Citation><ArticleIdList><ArticleId IdType="pubmed">33001179</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher F., Westermann D., Gaub R., Pronk J., Bock T., Al-Saadi N., et al. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart. 2011;97:709&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">21134904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi A., Perazzolo Marra M., Rigato I., De Lazzari M., Susana A., Niero A., et al. Nonischemic Left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ Arrhythm Electrophysiol. 2016;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956679</ArticleId><ArticleId IdType="pubmed">27390211</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy A., Brodsky N.N., Sumida T.S., Comi M., Asashima H., Hoehn K.B., et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity. 2021;54:1083&#x2013;1095 e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043654</ArticleId><ArticleId IdType="pubmed">33891889</ArticleId></ArticleIdList></Reference><Reference><Citation>Group R.C., Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., et al. Dexamethasone in hospitalized patients with COVID-19. N&#xa0;Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P.W., Mafham M., Bell J.L., Linsell L., Staplin N., Emberson J., et al. Lopinavir;ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396:1345&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535623</ArticleId><ArticleId IdType="pubmed">33031764</ArticleId></ArticleIdList></Reference><Reference><Citation>Group R.C., Horby P., Mafham M., Linsell L., Bell J.L., Staplin N., et al. Effect of hydroxychloroquine in hospitalized patients with COVID-19. N&#xa0;Engl J Med. 2020;383:2030&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556338</ArticleId><ArticleId IdType="pubmed">33031652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi L.A., Colussi G., Bulfone L., Brosolo G., Da Porto A., Peghin M., et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol. 2021:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820534</ArticleId><ArticleId IdType="pubmed">33481096</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>